Annual FCF
-$56.18 M
+$29.39 M+34.35%
December 31, 2023
Summary
- As of February 26, 2025, ELEV annual free cash flow is -$56.18 million, with the most recent change of +$29.39 million (+34.35%) on December 31, 2023.
- During the last 3 years, ELEV annual FCF has fallen by -$43.81 million (-354.20%).
- ELEV annual FCF is now -354.20% below its all-time high of -$12.37 million, reached on December 31, 2020.
Performance
ELEV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$8.38 M
-$177.00 K-2.16%
September 30, 2024
Summary
- As of February 26, 2025, ELEV quarterly free cash flow is -$8.38 million, with the most recent change of -$177.00 thousand (-2.16%) on September 30, 2024.
- Over the past year, ELEV quarterly FCF has stayed the same.
- ELEV quarterly FCF is now -426.18% below its all-time high of -$1.59 million, reached on March 31, 2020.
Performance
ELEV Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$38.34 M
+$4.97 M+11.48%
September 30, 2024
Summary
- As of February 26, 2025, ELEV TTM free cash flow is -$38.34 million, with the most recent change of +$4.97 million (+11.48%) on September 30, 2024.
- Over the past year, ELEV TTM FCF has stayed the same.
- ELEV TTM FCF is now -2306.97% below its all-time high of -$1.59 million, reached on March 31, 2020.
Performance
ELEV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ELEV Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.4% | 0.0% | 0.0% |
| 3 y3 years | -354.2% | +53.0% | +55.2% |
| 5 y5 years | - | +53.0% | +55.2% |
ELEV Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.2% | +34.4% | -2.2% | +81.1% | -27.1% | +58.7% |
| 5 y | 5-year | -354.2% | +34.4% | -426.2% | +81.1% | -2307.0% | +58.7% |
| alltime | all time | -354.2% | +34.4% | -426.2% | +81.1% | -2307.0% | +58.7% |
Elevation Oncology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.38 M(+2.2%) | -$38.34 M(-11.5%) |
| Jun 2024 | - | -$8.21 M(-14.3%) | -$43.32 M(-11.5%) |
| Mar 2024 | - | -$9.57 M(-21.4%) | -$48.92 M(-12.9%) |
| Dec 2023 | -$56.18 M(-34.3%) | -$12.18 M(-8.8%) | -$56.18 M(-9.2%) |
| Sep 2023 | - | -$13.36 M(-3.3%) | -$61.85 M(-33.3%) |
| Jun 2023 | - | -$13.81 M(-17.9%) | -$92.76 M(+5.0%) |
| Mar 2023 | - | -$16.83 M(-5.7%) | -$88.38 M(+3.3%) |
| Dec 2022 | -$85.57 M | -$17.85 M(-59.7%) | -$85.57 M(+11.7%) |
| Sep 2022 | - | -$44.27 M(+369.6%) | -$76.63 M(+90.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$9.43 M(-32.8%) | -$40.27 M(+16.0%) |
| Mar 2022 | - | -$14.02 M(+57.3%) | -$34.71 M(+15.1%) |
| Dec 2021 | -$30.17 M(+143.9%) | -$8.91 M(+12.8%) | -$30.17 M(+22.5%) |
| Sep 2021 | - | -$7.90 M(+104.1%) | -$24.64 M(+14.8%) |
| Jun 2021 | - | -$3.87 M(-59.1%) | -$21.46 M(+6.3%) |
| Mar 2021 | - | -$9.48 M(+180.1%) | -$20.18 M(+64.1%) |
| Dec 2020 | -$12.37 M | -$3.38 M(-28.4%) | -$12.30 M(+37.9%) |
| Sep 2020 | - | -$4.73 M(+82.2%) | -$8.91 M(+112.9%) |
| Jun 2020 | - | -$2.60 M(+62.9%) | -$4.19 M(+162.9%) |
| Mar 2020 | - | -$1.59 M | -$1.59 M |
FAQ
- What is Elevation Oncology annual free cash flow?
- What is the all time high annual FCF for Elevation Oncology?
- What is Elevation Oncology annual FCF year-on-year change?
- What is Elevation Oncology quarterly free cash flow?
- What is the all time high quarterly FCF for Elevation Oncology?
- What is Elevation Oncology quarterly FCF year-on-year change?
- What is Elevation Oncology TTM free cash flow?
- What is the all time high TTM FCF for Elevation Oncology?
- What is Elevation Oncology TTM FCF year-on-year change?
What is Elevation Oncology annual free cash flow?
The current annual FCF of ELEV is -$56.18 M
What is the all time high annual FCF for Elevation Oncology?
Elevation Oncology all-time high annual free cash flow is -$12.37 M
What is Elevation Oncology annual FCF year-on-year change?
Over the past year, ELEV annual free cash flow has changed by +$29.39 M (+34.35%)
What is Elevation Oncology quarterly free cash flow?
The current quarterly FCF of ELEV is -$8.38 M
What is the all time high quarterly FCF for Elevation Oncology?
Elevation Oncology all-time high quarterly free cash flow is -$1.59 M
What is Elevation Oncology quarterly FCF year-on-year change?
Over the past year, ELEV quarterly free cash flow has changed by $0.00 (0.00%)
What is Elevation Oncology TTM free cash flow?
The current TTM FCF of ELEV is -$38.34 M
What is the all time high TTM FCF for Elevation Oncology?
Elevation Oncology all-time high TTM free cash flow is -$1.59 M
What is Elevation Oncology TTM FCF year-on-year change?
Over the past year, ELEV TTM free cash flow has changed by $0.00 (0.00%)